ACETYLON PHARMACEUTICALS
Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company was incorporated in 2008 and is based in Boston, Massachusetts.
ACETYLON PHARMACEUTICALS
Industry:
Biotechnology Health Care Manufacturing Medical Device Pharmaceutical
Founded:
2008-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.acetylon.com
Total Employee:
11+
Status:
Active
Contact:
(617) 245-1300
Email Addresses:
[email protected]
Total Funding:
151.25 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Proofpoint CSC Global DNS MediaMath BlueKai BlueKai DMP
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Anacor Pharmaceutical
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Celgene
Celgene investment in Private Equity Round - Acetylon Pharmaceuticals
Celgene
Celgene investment in Private Equity Round - Acetylon Pharmaceuticals
The Kraft Group
The Kraft Group investment in Series A - Acetylon Pharmaceuticals
Cobro Ventures
Cobro Ventures investment in Seed Round - Acetylon Pharmaceuticals
Official Site Inspections
http://www.acetylon.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acetylon Pharmaceuticals"
Acetylon Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Acetylon Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Acetylon Pharmaceuticals, Inc. …See details»
Acetylon Pharmaceuticals - EquityNet
Dr. joined Acetylon in September 2009 from EPIX Pharmaceuticals Inc., where he was Vice President of Biology and ADMET. Prior to EPIX, Dr. held senior level positions in drug …See details»
Acetylon Pharmaceuticals - Products, Competitors, Financials, …
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other …See details»
Acetylon Pharmaceuticals - Ownership and Business Overview
Acetylon Pharmaceuticals, Inc. is building on the promise of epigenetics by applying its unique capabilities to discover and develop next-generation, selective small molecule drugs for the …See details»
Boston’s Acetylon Gets Taken Out By Celgene, Will Spin Out
December 5, 2016 By Mark Terry, BioSpace.com Breaking News Staff. Summit, NJ-based Celgene announced Friday that it will be acquiring Boston-based Acetylon Pharmaceuticals.In …See details»
Celgene acquires Acetylon, spins out Regenacy - MedCity News
Dec 2, 2016 The remainder of Acetylon’s portfolio will be spun out to form a new company called Regenacy Pharmaceuticals. It too will establish a program to further ricolinostat, but only in …See details»
Acetylon Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
Mar 7, 2025 Acetylon Pharmaceuticals, Inc. is likely collaborating with other organizations, such as research institutions and pharmaceutical companies, to advance the development of …See details»
Acetylon Pharmaceuticals, Inc. (Acetylon Pharmaceuticals, Inc.) - 药 …
Acetylon Pharmaceuticals, Inc. is likely collaborating with other organizations, such as research institutions and pharmaceutical companies, to advance the development of Citarinostat. In …See details»
Acetylon Pharmaceuticals, Inc. | LinkedIn
Acetylon Pharmaceuticals, Inc. | 891 seguidores en LinkedIn. Acetylon Pharmaceuticals is pursuing development of next-generation, selective histone deacetylase (HDAC) enzyme …See details»
Acetylon Pharmaceuticals, Inc.:Company Profile & Technical …
Acetylon Pharmaceuticals, Inc. is a company that provides Medicine, Medical equipment, Histone deacetylase and more. Acetylon Pharmaceuticals, Inc. is headquartered in United States …See details»
Ken Anderson - Member of the Board of Directors
Ken Anderson, MD. Kraft Family Professor of Medicine, Harvard Medical School. Director, Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics. Co-founder of Acetylon Pharmaceuticals, OncoPep. …See details»
Acetylon Pharmaceuticals Culture | Comparably
Learn about Acetylon Pharmaceuticals' culture, see what work's like, read reviews, and find job opportunities.See details»
Cambridge startup launches HDAC platform with Series A
Aug 7, 2009 Cambridge, MA-based startup Acetylon Pharmaceuticals is taking the wraps off a $7.25 million Series A later today as it sets out to zero in on a lead program and demonstrate …See details»
Acetylon Announces Addition of Catherine A. Wheeler MD as Vice ...
Dec 12, 2011 Acetylon Pharmaceuticals, Inc. Walter C. Ogier, 617-638-0460 President and Chief Executive Officer [email protected] or Media: MacDougall Biomedical CommunicationsSee details»
Celgene spends $100M for option to buy myeloma drug …
Jul 29, 2013 Summit, NJ-based Celgene, which initially invested $15 million in Acetylon early last year, has agreed to terms that could lead to a buyout of the startup worth $1.7 billion.See details»
Trimmed-down Acetylon proves more attractive to former opt-in …
Dec 5, 2016 After passing on an option to buy Acetylon in the summer, Celgene has come back with an offer for a slimmed-down version of the biotech. Celgene's interest in the histone …See details»
Marc Cohen - Crunchbase Person Profile
Jul 30, 2013 Organization Name . Title At Company . Start Date . End Date . AI Proteins . Co-founder: Nov 2021: Jan 2022: Acetylon Pharmaceuticals . Chairman and Co-Founder: Aug …See details»
Harvard University and Dana-Farber Cancer Institute Grant …
Mar 9, 2010 The exclusive therapeutic license is granted for a breakthrough discovery platform for next generation HDAC inhibitors.See details»
Acetylon Pharmaceuticals Initiates New Phase 1b Clinical Trial of ...
Aug 1, 2012 Acetylon Pharmaceuticals, Inc.Walter C. Ogier, 617-245-1300President and Chief Executive OfficerorMEDIA:MacDougall Biomedical CommunicationsKari Watson, 781-235 …See details»
Acetylene Plant Manufacturer | Acetylene Plants | sanghi - Sanghi …
The Acetylene Plants from Sanghi Organization are of indigenous manufacture. Every part has been carefully designed by experienced engineers. These parts are made of the best material. …See details»